Should oxytocin be continued after active labor has been established?

The appropriate management of oxytocin administration after active labor has been established is critical in the context of fetal monitoring and labor management. Continuing oxytocin after the onset of active labor is contingent upon the clinical situation and the patient’s response to labor.

In many cases, it is recommended to discontinue or titrate down the use of oxytocin once active labor is established and adequate contractions are occurring, as ongoing administration may lead to excessively frequent contractions, which can cause uterine hyperstimulation. Uterine hyperstimulation can compromise fetal well-being, as it may lead to decreased uteroplacental perfusion resulting in fetal distress.

Therefore, the decision to continue oxytocin should be carefully considered and is often based on the adequacy of uterine contractions. If contractions are sufficient and labor progress is being achieved satisfactorily, maintaining oxytocin is not necessary and may even pose risks. It is crucial for healthcare providers to continuously assess both maternal and fetal status before making decisions regarding ongoing oxytocin administration during the active phase of labor.